Combating dangerous medicines: Differences in quality of medicines sold by small pharmacies and large chain pharma

Summary

Evidence from numerous studies shows that emerging markets have far more poor quality drugs than western markets. There are many reasons for this, but one reason, investigated in this paper, is the possibility that smaller, often privately-owned, pharmacies take greater risks with drug procurement than larger organizations, which are often franchises or major pharmacy chains.  The limited data available weakly support the hypothesis, with 14.4% of samples from smaller pharmacies failing quality control and 9.4% of samples from larger pharmacies failing. Ongoing research will hopefully provide a more robust testing of the hypothesis, as well as provide a fuller explanation.

Click here to view the full tex of this working paper as an Adobe Acrobat PDF.

Roger Bate is the Legatum Fellow at AEI.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

'Just win, baby': The politics of Obamacare
image Ring the alarm bells over Puerto Rico
image US oil production keeps surging, so why haven’t oil and gasoline prices fallen?
image How 'Captain America' conquered China — and why it matters
AEI on Facebook
Events Calendar
  • 18
    MON
  • 19
    TUE
  • 20
    WED
  • 21
    THU
  • 22
    FRI
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.